An intervention meant to foster a positive outlook significantly improved endothelial function and lowered blood pressure, show preliminary results of the FEEL study.
The PROACT trial assessing enalapril in patients with cancer undergoing chemotherapy showed this approach did not affect cardiac function or the rate of cardiac injury.
A telemedicine program for patients with acute coronary syndrome discharged after percutaneous coronary intervention improved outcomes significantly compared with standard care.
ApoA1 infusions in acute MI did not significantly reduce the composite endpoint in the AEGIS-II trial. However, an exploratory analysis suggested benefit at higher LDL levels.